Search results

Found 150 pages
AUTHOR: PharmaTimes Reporter

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

Bayer plans corporate restructure

Bayer is developing plans to overhaul its corporate structure to more closely align its two life sciences businesses, but says the move will not see any staff reductions. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/bayer_plans_corporate_restructure_971447

NICE recommends new licences for autoinflammatory disorders

After two months of not issuing guidance due to the UK’s General Election, NICE has today published a host of new recommendations for a number of drugs. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/nice_recommends_new_licences_for_autoinflammatory_disorders_971452

Sanofi’s Jevtana given last-minute CDF reprieve

Sanofi has reached an eleventh hour reprieve with NHS England that will see its advanced prostate cancer drug Jevtana (cabazitaxel) once more become available on the NHS. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/sanofis_jevtana_given_last-minute_cdf_reprieve_971446

Astellas completes 800 million euro biotech acquisition

Belgium’s Ogeda is now a wholly-owned subsidiary of the Japanese pharma firm - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/astellas_completes_800_million_euro_biotech_acquisition_1193032

Better diabetic foot care 'could save NHS £250m'

NHS England could significantly cut its spending on diabetes foot care by introducing or rearranging specialist foot services, according to a leading charity. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/better_diabetic_foot_care_could_save_nhs_250m_1187552

Novartis' Jakavi gets yes in Europe

Novartis has been given the green light in Europe for Jakavi to treat a rare blood cancer.  - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/novartis_jakavi_gets_yes_in_europe_971191

UK CRO Quanticate doubles its footprint in India

Opens new Bangalore office to bolster its global offering - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/uk_cro_quanticate_doubles_its_footprint_in_india_1206470

Latest jobs from #PharmaRole

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download